Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN · IEX Real-Time Price · USD
0.923
-0.014 (-1.54%)
At close: May 16, 2022 4:00 PM
0.910
-0.013 (-1.408%)
After-hours:May 16, 2022 7:59 PM EDT

Total Valuation

Alzamend Neuro has a market cap or net worth of $85.86 million. The enterprise value is $74.07 million.

Market Cap85.86M
Enterprise Value74.07M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Alzamend Neuro has 93.02 million shares outstanding. The number of shares has increased by 30.31% in one year.

Shares Outstanding93.02M
Shares Change (YoY)+30.31%
Shares Change (QoQ)+0.76%
Owned by Insiders (%)48.58%
Owned by Institutions (%)3.64%
Float50.34M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio7.18
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

Current Ratio26.62
Quick Ratio25.25
Debt / Equity0.00
Debt / EBITDA0.00
Debt / FCF0.00

Financial Efficiency

Return on equity (ROE) is -92.10%, which is considered low. The company has a ROIC of -8,505.10%.

Return on Equity (ROE)-92.10%
Return on Assets (ROA)-83.60%
Return on Capital (ROIC)-8,505.10%
Revenue Per Employeen/a
Profits Per Employee-$3.25M
Employee Count3
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (1Y)n/a
Total Price Change-81.80%
50-Day Moving Average1.04
200-Day Moving Average1.59
Average Volume (30 Days)1,326,103

Short Selling Information

The latest short interest is 1.60 million, so 1.72% of the outstanding shares have been sold short.

Short Interest1.60M
Short % of Shares Out1.72%
Short % of Float3.18%
Short Ratio (days to cover)1.10

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-9.67M
Net Income-9.75M
EBITDA-9.67M
EBIT-9.67M
Earnings Per Share (EPS)-$0.11
Full Income Statement

Balance Sheet

The company has $11.79 million in cash and no debt, giving a net cash position of $11.79 million or $0.13 per share.

Cash & Cash Equivalents11.79M
Total Debt0
Net Cash11.79M
Net Cash Per Share$0.13
Book Value11.96M
Book Value Per Share0.13
Working Capital11.96M
Full Balance Sheet

Cash Flow

Operating Cash Flow-6.31M
Capital Expendituresn/a
Free Cash Flow-6.31M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Alzamend Neuro does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-11.36%
FCF Yield-7.35%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yield-30.31%
Shareholder Yield-30.31%
Dividend Details

Analyst Forecast

The average price target for Alzamend Neuro is $11.48, which is 1,143.77% higher than the current price. The consensus rating is "Buy".

Price Target$11.48
Price Target Difference1,143.77%
Analyst ConsensusBuy
Analyst Count8
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a